QCG
BPMC
Quadrant Capital Group’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3
| Closed | -$266 | – | 1517 |
|
|
2025
Q1 | $266 | Hold |
3
| – | – | ﹤0.01% | 2702 |
|
|
2024
Q4 | $262 | Sell |
3
-37
| -93% | -$3.23K | ﹤0.01% | 2690 |
|
|
2024
Q3 | $3.7K | Hold |
40
| – | – | ﹤0.01% | 2380 |
|
|
2024
Q2 | $4.31K | Hold |
40
| – | – | ﹤0.01% | 2335 |
|
|
2024
Q1 | $3.8K | Sell |
40
-22
| -35% | -$2.09K | ﹤0.01% | 2380 |
|
|
2023
Q4 | $5.72K | Buy |
62
+59
| +1,967% | +$5.44K | ﹤0.01% | 2238 |
|
|
2023
Q3 | $151 | Sell |
3
-139
| -98% | -$7K | ﹤0.01% | 2658 |
|
|
2023
Q2 | $8.98K | Buy |
142
+139
| +4,633% | +$8.79K | ﹤0.01% | 2042 |
|
|
2023
Q1 | $135 | Sell |
3
-27
| -90% | -$1.22K | ﹤0.01% | 2695 |
|
|
2022
Q4 | $1.31K | Buy |
30
+9
| +43% | +$394 | ﹤0.01% | 2494 |
|
|
2022
Q3 | $1K | Sell |
21
-48
| -70% | -$2.29K | ﹤0.01% | 2476 |
|
|
2022
Q2 | $3K | Buy |
69
+60
| +667% | +$2.61K | ﹤0.01% | 2088 |
|
|
2022
Q1 | $1K | Sell |
9
-5
| -36% | -$556 | ﹤0.01% | 2255 |
|
|
2021
Q4 | $1K | Sell |
14
-26
| -65% | -$1.86K | ﹤0.01% | 2258 |
|
|
2021
Q3 | $4K | Buy |
40
+31
| +344% | +$3.1K | ﹤0.01% | 1922 |
|
|
2021
Q2 | $1K | Sell |
9
-16
| -64% | -$1.78K | ﹤0.01% | 2226 |
|
|
2021
Q1 | $2K | Buy |
25
+21
| +525% | +$1.68K | ﹤0.01% | 2027 |
|
|
2020
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 2301 |
|
|
2020
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 2168 |
|
|
2020
Q2 | $0 | Sell |
4
-965
| -100% | – | ﹤0.01% | 2224 |
|
|
2020
Q1 | $56K | Buy |
969
+864
| +823% | +$49.9K | 0.01% | 826 |
|
|
2019
Q4 | $8K | Sell |
105
-254
| -71% | -$19.4K | ﹤0.01% | 1949 |
|
|
2019
Q3 | $26K | Hold |
359
| – | – | ﹤0.01% | 1498 |
|
|
2019
Q2 | $33K | Buy |
+359
| New | +$33K | 0.01% | 1386 |
|